Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FUS Instruments is a private Canadian medical device and research tools company focused on preclinical focused ultrasound systems, particularly for brain research. The company develops turn-key stereotactic and MRI-guided focused ultrasound platforms, MRI-compatible transducers, RF coils, water degassers, and related accessories for academic, clinical, and industry researchers. Its systems are used to study applications such as blood-brain barrier opening, neuromodulation, hyperthermia, ablation, and targeted drug delivery. Founded by therapeutic ultrasound scientists Rajiv Chopra and Kullervo Hynynen, the company is closely connected to the Sunnybrook research ecosystem in Toronto. FUS Instruments appears to be commercially active and primarily serves the preclinical research market rather than advancing its own therapeutic drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FUS Instruments.